No association of plasma levels of adiponectin and c-peptide with risk of aggressive prostate cancer in the cancer prevention study II nutrition cohort

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 5, 2014, Pages 890-892

  Stevens, Victoria L ^a   Jacobs, Eric J ^a   Sun, Juzhong ^a   Gapstur, Susan M ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C PEPTIDE; INSULIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; GLEASON SCORE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; BLOOD; CANCER STAGING; COMPARATIVE STUDY; METABOLISM; NUTRITIONAL STATUS; OBESITY; PATHOPHYSIOLOGY; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; C-PEPTIDE; CASE-CONTROL STUDIES; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; INSULIN; MALE; NEOPLASM STAGING; NUTRITIONAL STATUS; OBESITY; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84899753813     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0114     Document Type: Article

References (8)

1. Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol 2013;63: 800-9.
2. Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev 2012;33: 547-94.
3. Djiogue S, Nwabo Kamdje AH, Vecchio L, Kipanyula MJ, Farahna M, Aldebasi Y, et al. Insulin resistance and cancer: the role of insulin and IGFs. Endocr Relat Cancer 2013;20:R1-17.
4. Li H, Stampfer MJ, Mucci L, Rifai N, Qiu W, Kurth T, et al. A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. Clin Chem 2010;56: 34-43.
5. Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, Sutton A, et al. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study. Am J Epidemiol 2013;177: 3-13.
6. Pierce BL. Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence. Urol Oncol 2012;30: 735-43.
7. Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort. Cancer 2002;94: 2490-501.
8. Mohler J, Bahnson RR, Boston B, Busby JE, D'Amico A, Eastham JA, et al. NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 2010;8: 162-200.